Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Imperative Care

Explore full profile

Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke

Campbell, United StatesFounded 2015Health Tech & Medtech
Valuation $1–2.5B Last recorded · 2024
Revenue $100–500M Latest reported FY
Headcount 100–500 Current team size
Total funding $500M–1B Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Imperative Care and the history behind them.

About Imperative Care

Imperative Care is a healthcare technology startup that focuses on developing innovative solutions for patients suffering from stroke and other vascular diseases. The company operates in the medical technology market, specifically targeting the needs of physicians and their patients.

Imperative Care's business model is centered around the rapid development and testing of new technologies, with a strong emphasis on clinical evidence and physician feedback. This approach allows the company to quickly respond to the changing needs of the medical community and their patients. The company's commitment to research and development is demonstrated through various clinical trials, including the large-scale, multicenter Imperative Trial.

The company's leadership team is composed of experienced professionals in the field of stroke product development, clinical research, marketing, strategy, and business development. The team's expertise and dedication to stroke care have been instrumental in the company's growth and success.

Imperative Care generates revenue through the sale of its innovative medical technologies to healthcare providers. The company's products are designed to improve the quality of care for stroke patients, and as such, they are marketed towards physicians and healthcare institutions that treat these patients.

In summary, Imperative Care is a dynamic player in the medical technology market, with a strong focus on improving the care and outcomes for stroke patients. The company's commitment to innovation, clinical evidence, and physician feedback sets it apart from its competitors and positions it for future growth.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
Campbell, United States
Employees
412
Open positions
15
Dealroom signal
92.3/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Surgery, Cardiology and cardiovascular, Tech for Hospitals and Clinics, Rumoured $1B, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Client focus
b2b

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
CONVERTIBLEOther financing Mar 2026 $100M — Ally Bridge Group · Bain Capital Life Sciences · Perceptive Advisors · Brown Advisory ↗
SERIES EOther financing Jul 2024 $150M $1.3B Pura Vida Investments · AMED Ventures · Ally Bridge Group · Montreux Equity Partners ↗
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Imperative Care website traffic

Latest recorded traffic for Imperative Care is 11K monthly website visits, up 100% over the last three months. Imperative Care's team grew 11.4% over the past year.

Latest monthly visits11K 3-month web change+100% 1-year team growth+11.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

17 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

Series B and later13 investors entered at this stage

  • Ally Bridge Group
  • Bain Capital Life Sciences
  • Ascension
  • Delos Capital
  • Rock Springs Capital
  • Innovatus Capital Partners
  • D1 Capital Partners
  • AMED Ventures
  • HealthCor Management
  • Pura Vida Investments
  • Montreux Equity Partners
  • Catalio Capital Management
  • INTAI Technology Corp
Team profiled 15 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States99.7%
🇦🇪 United Arab Emirates0.3%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Imperative Care on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Imperative Care’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.